Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Validation of the Use of Apixaban As an Alternate Anticoagulant for the Management of Patients with Heparin-Induced Thrombocytopenia.

Jeanine M. Walenga, PhD, Margaret Prechel, Debra Hoppensteadt, Vicki Escalante, BS, Talhah Chaudhry, Walter Jeske, PhD, Mamdouh Bakhos, MD

Blood (2012) 120 (21): 2265.

https://doi.org/10.1182/blood.V120.21.2265.2265

Published: 2012

Journal Articles

Early Management of Heparin-Induced Thrombocytopenia Using a Simple Scoring System

Harry L. Messmore, Jr., MD, Nancy Fabbrini, MT(ASCP), Mary L. Bird, MD, Abdul M. Choudhury, MD, Miguel Cerejo, MD, M. Margaret Prechel, PhD, Walter Jeske, PhD, Arshea Siddiqui, M.D., Indermohan Thethi, MD, William H. Wehrmacher, M.D., Jeanine M. Walenga, PhD

Blood (2011) 118 (21): 4679.

https://doi.org/10.1182/blood.V118.21.4679.4679

Published: 2011

Journal Articles

A Novel, Colorimetric Platelet Activation Assay for Diagnosis of Heparin Induced Thrombocytopenia

M. Margaret Prechel, PhD, Vicki Escalante, BS, Amanda F. Drenth, BS, Jeanine M. Walenga, PhD

Blood (2010) 116 (21): 5127.

https://doi.org/10.1182/blood.V116.21.5127.5127

Published: 2010

Journal Articles

Novel Antagonists for Low Molecular Weight Heparin and Heparin-Like Drugs.

Walter Jeske, Ph.D., Christine Schroeder, Margaret Prechel, Ph.D., Jeanine M. Walenga, PhD, Mamdouh Bakhos, M.D.

Blood (2009) 114 (22): 2092.

https://doi.org/10.1182/blood.V114.22.2092.2092

Published: 2009

Journal Articles

Cross Reactivity of Heparin-Induced PF4 Antibodies with Heparin- Bound IL-8.

Margaret Prechel, PhD, Abigail M Hilby, BS, Jeanine M. Walenga, PhD

Blood (2008) 112 (11): 3429.

https://doi.org/10.1182/blood.V112.11.3429.3429

Published: 2008

Journal Articles

Methodologic Variations in the Determinations of Anti-Platelet Factor 4-Heparin Antibodies in Patients Suspected of Having Heparin Induced Thrombocytopenia: Diagnostic and Prognostic Implications.

Jawed Fareed, PhD, Margaret Prechel, Ph.D., Michelle Kujawski, Ph.D., He Zhu, Ph.D., Jeanine Walenga, Ph.D., Debra Hoppensteadt, Ph.D., Josephine Cunanan, M.D., Renu Saxena, M.D.

Blood (2007) 110 (11): 3206.

https://doi.org/10.1182/blood.V110.11.3206.3206

Published: 2007

Journal Articles

A Unique Biomarker Is Associated with the Prevalence of Functional Heparin Induced Thrombocytopenia (HIT) Associated Antibodies: Results from Proteomic (ProteinChip Array) Profiling of ELISA Positive HIT Plasma Samples.

Michelle R. Kujawski, PhD, Margaret Prechel, Ph.D., He Zhu, M.D., Jeanine Walenga, Ph.D., Debra Hoppensteadt, Ph.D., Josephine Cunanan, M.D., Cafer Adiguzel, M.D., Jawed Fareed, Ph.D.

Blood (2007) 110 (11): 3205.

https://doi.org/10.1182/blood.V110.11.3205.3205

Published: 2007

Journal Articles

Functional Microparticles Are up Regulated in Patients with Anti-Heparin/Platelet Factor 4 Antibodies: A Potential Mechanism of Thrombogenesis in the Heparin-Induced Thrombocytopenia Syndrome.

Josephine Cunanan, MD, Michelle Kujawski, Ph.D., He Zhu, M.D., Margaret Prechel, Ph.D., Jeanine Walenga, Ph.D., Debra Hoppensteadt, Ph.D., Jawed Fareed, Ph.D.

Blood (2007) 110 (11): 2105.

https://doi.org/10.1182/blood.V110.11.2105.2105

Published: 2007

Journal Articles

The Oral, Direct Factor Xa Inhibitor BAY 59-7939 Does Not Cross-React with Anti-Heparin/PF4 (Heparin-Induced Thrombocytopenia) Antibodies.

Jeanine M. Walenga, PhD, Debra Hoppensteadt, PhD, Omer Iqbal, MD, Brian Neville, PhD, Walter P. Jeske, PhD, Margaret Prechel, PhD, Harry L. Messmore, PhD, Frank Misselwitz, MD, PhD, Mamdouh Bakhos, PhD

Blood (2005) 106 (11): 1883.

https://doi.org/10.1182/blood.V106.11.1883.1883

Published: 2005

Journal Articles

Novel Single Agents with Combined Anti-Coagulant and Anti-Platelet Activities: Potential Treatment Option for the Management of HIT.

Jeanine M. Walenga, PhD, Margaret Prechel, PhD, Walter P. Jeske, PhD, Meredith K. McDonald, BS, James M. Daikur, BS, Wasimul Haque, PhD

Blood (2005) 106 (11): 1884.

https://doi.org/10.1182/blood.V106.11.1884.1884

Published: 2005

Journal Articles

The Impact of Non-H:PF4 Antibodies on Results of the Serotonin Release Assay for Heparin-Induced Thrombocytopenia.

M. Margaret Prechel, PhD, Maura A. Woznica, BA, Meredith K. McDonald, BS, Walter P. Jeske, PhD, Jeanine M. Walenga, PhD

Blood (2005) 106 (11): 3952.

https://doi.org/10.1182/blood.V106.11.3952.3952

Published: 2005

Journal Articles

SRA Does Not Detect Potentially Relevant HIT Antibodies.

Margaret Prechel, Ph.D., Meredith K. McDonald, B.S., Walter P. Jeske, Ph.D., Amanda F. Drenth, B.S., Jeanine M. Walenga, Ph.D.

Blood (2004) 104 (11): 3028.

https://doi.org/10.1182/blood.V104.11.3028.3028

Published: 2004

Journal Articles

Desulfated Heparin Blocks Platelet Activation Induced by HIT Antibodies / Heparin: A New Approach to Patient Management.

Margaret Prechel, PhD, Walter P. Jeske, PhD, Meredith K. McDonald, BS, Amanda F. Drenth, BS, Jeanine M. Walenga, PhD

Blood (2004) 104 (11): 3029.

https://doi.org/10.1182/blood.V104.11.3029.3029

Published: 2004

Journal Articles

Comparison of Three Tests for Confirmation of the Diagnosis of Heparin Induced Thrombocytopenia.

Harry L. Messmore, MD, Abdul M. Choudhury, MD, Nancy J. Fabbrini, BS, Mary L. Bird, MD, Thomas Moritz, MS, Lizzy Thottapurathu, MS, William H. Wehrmacher, MD, Margaret Prechel, PhD, Jeanine M. Walenga, PhD, Thelma J. Crosby, MT, Betty C. Love, BS, Courtney A. Zarr, BS, Beth E. Griffin, BS, Sanober S. Balbale, BS

Blood (2004) 104 (11): 2075.

https://doi.org/10.1182/blood.V104.11.2075.2075

Published: 2004

NARROW

Validation of the Use of Apixaban As an Alternate Anticoagulant for the Management of Patients with Heparin-Induced Thrombocytopenia.

Early Management of Heparin-Induced Thrombocytopenia Using a Simple Scoring System

A Novel, Colorimetric Platelet Activation Assay for Diagnosis of Heparin Induced Thrombocytopenia

Novel Antagonists for Low Molecular Weight Heparin and Heparin-Like Drugs.

Cross Reactivity of Heparin-Induced PF4 Antibodies with Heparin- Bound IL-8.

Methodologic Variations in the Determinations of Anti-Platelet Factor 4-Heparin Antibodies in Patients Suspected of Having Heparin Induced Thrombocytopenia: Diagnostic and Prognostic Implications.

A Unique Biomarker Is Associated with the Prevalence of Functional Heparin Induced Thrombocytopenia (HIT) Associated Antibodies: Results from Proteomic (ProteinChip Array) Profiling of ELISA Positive HIT Plasma Samples.

Functional Microparticles Are up Regulated in Patients with Anti-Heparin/Platelet Factor 4 Antibodies: A Potential Mechanism of Thrombogenesis in the Heparin-Induced Thrombocytopenia Syndrome.

The Oral, Direct Factor Xa Inhibitor BAY 59-7939 Does Not Cross-React with Anti-Heparin/PF4 (Heparin-Induced Thrombocytopenia) Antibodies.

Novel Single Agents with Combined Anti-Coagulant and Anti-Platelet Activities: Potential Treatment Option for the Management of HIT.

The Impact of Non-H:PF4 Antibodies on Results of the Serotonin Release Assay for Heparin-Induced Thrombocytopenia.

SRA Does Not Detect Potentially Relevant HIT Antibodies.

Desulfated Heparin Blocks Platelet Activation Induced by HIT Antibodies / Heparin: A New Approach to Patient Management.

Comparison of Three Tests for Confirmation of the Diagnosis of Heparin Induced Thrombocytopenia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only